|
1
|
Miyoshi Y, Nagase H, Ando H, Horii A,
Ichii S, Nakatsuru S, Aoki T, Miki Y, Mori T and Nakamura Y:
Somatic mutations of the APC gene in colorectal tumors: mutation
cluster region in the APC gene. Hum Mol Genet. 1:229–233. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Morin PJ, Sparks AB, Korinek V, Barker N,
Clevers H, Vogelstein B and Kinzler KW: Activation of
beta-catenin-Tcf signaling in colon cancer by mutations in
beta-catenin or APC. Science. 275:1787–1790. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Schneikert J and Behrens J: The canonical
Wnt signalling pathway and its APC partner in colon cancer
development. Gut. 56:417–425. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Durai R, Yang W, Gupta S, Seifalian AM and
Winslet MC: The role of the insulin-like growth factor system in
colorectal cancer: review of current knowledge. Int J Colorectal
Dis. 20:203–220. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Degeorges A, Wang F, Frierson HF Jr, Seth
A and Sikes RA: Distribution of IGFBP-rP1 in normal human tissues.
J Histochem Cytochem. 48:747–754. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Burger AM, Leyland-Jones B, Banerjee K,
Spyropoulos DD and Seth AK: Essential roles of IGFBP-3 and
IGFBP-rP1 in breast cancer. Eur J Cancer. 41:1515–1527. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sato Y, Chen Z and Miyazaki K: Strong
suppression of tumor growth by insulin-like growth factor-binding
protein-related protein 1/tumor-derived cell adhesion factor/mac25.
Cancer Sci. 98:1055–1063. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Georges RB, Adwan H, Hamdi H, Hielscher T,
Linnemann U and Berger MR: The insulin-like growth factor binding
proteins 3 and 7 are associated with colorectal cancer and liver
metastasis. Cancer Biol Ther. 12:69–79. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ruan WJ, Lin J, Xu EP, Xu FY, Ma Y, Dengh
H, Huang Q, Lv BJ, Hu H, Cui J, Di MJ, Dong JK and Lai MD: IGFBP7
plays a potential tumor suppressor role against colorectal
carcinogenesis with its expression associated with DNA
hypomethylation of exon 1. J Zhejiang Univ Sci B. 7:929–932. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ruan W, Xu E, Xu F, Ma Y, Deng H, Huang Q,
Lv B, Hu H, Lin J, Cui J, Di M, Dong J and Lai M: IGFBP7 plays a
potential tumor suppressor role in colorectal carcinogenesis.
Cancer Biol Ther. 6:354–359. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ye F, Chen Y, Knösel T, Schluns K,
Pacyna-Gengelbach M, Deutschmann N, Lai M and Petersen I: Decreased
expression of insulin-like growth factor binding protein 7 in human
colorectal carcinoma is related to DNA methylation. J Cancer Res
Clin Oncol. 133:305–314. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mälarstig A, Wågsäter D, Löfgren S,
Hugander A, Zar N and Dimberg J: Tumor-derived adhesion factor in
colorectal cancer. Mol Med Rep. 2:971–976. 2009.
|
|
13
|
Kondo Y and Issa JP: Epigenetic changes in
colorectal cancer. Cancer Metastasis Rev. 23:29–39. 2004.
View Article : Google Scholar
|
|
14
|
Venkatachalam R, Ligtenberg MJ,
Hoogerbrugge N, de Bruijn DR, Kuiper RP and Geurts van Kessel A:
The epigenetics of (hereditary) colorectal cancer. Cancer Genet
Cytogenet. 203:1–6. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jones PA and Baylin SB: The epigenomics of
cancer. Cell. 128:683–692. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Naghibalhossaini F, Zamani M, Mokarram P,
Khalili I, Rasti M and Mostafavi-Pour Z: Epigenetic and genetic
analysis of WNT signaling pathway in sporadic colorectal cancer
patients from Iran. Mol Biol Rep. 39:6171–6178. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Esteller M, Sparks A, Toyota M,
Sanchez-Cespedes M, Capella G, Peinado MA, Gonzales S, Tarafa G,
Sidransky D, Meltzer SJ, Baylin SB and Herman JG: Analysis of
adenomatous polyposis coli promoter hypermethylation in human
cancer. Cancer Res. 60:4366–4371. 2000.PubMed/NCBI
|
|
18
|
Lee S, Hwang KS, Lee HJ, Kim JS and Kang
GH: Aberrant CpG island hypermethylation of multiple genes in
colorectal neoplasia. Lab Invest. 84:884–893. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lee BB, Lee EJ, Jung EH, Chun HK, Chang
DK, Song SY, Park J and Kim DK: Aberrant methylation of APC, MGMT,
RASSF2A and Wif-1 genes in plasma as a biomarker for early
detection of colorectal cancer. Clin Cancer Res. 15:6185–6191.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen SP, Chiu SC, Wu CC, Lin SZ, Kang JC,
Chen YL, Lin PC, Pang CY and Harn HJ: The association of
methylation in the promoter of APC and MGMT and the prognosis of
Taiwanese CRC patients. Genet Test Mol Biomarkers. 13:67–71. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lin J, Lai M, Huang Q, Ruan W, Ma Y and
Cui J: Reactivation of IGFBP7 by DNA demethylation inhibits human
colon cancer cell growth in vitro. Cancer Biol Ther. 7:1896–1900.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen Y, Cui T, Knösel T, Yang L, Zöller K
and Petersen I: IGFBP7 is a p53 target gene inactivated in human
lung cancer by DNA hypermethylation. Lung Cancer. 73:38–44. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Smith P, Nicholson LJ, Syed N, Payne A,
Hiller L, Garrone O, Occelli M, Gasco M and Crook T: Epigenetic
inactivation implies independent functions for insulin-like growth
factor binding protein (IGFBP)-related protein 1 and related
IGFBPL1 in inhibiting breast cancer phenotypes. Clin Cancer Res.
13:4061–4068. 2007. View Article : Google Scholar
|
|
24
|
Herman JG, Graff JR, Myöhänen S, Nelkin BD
and Baylin SB: Methylation-specific PCR: A novel PCR assay
methylation status of CpG islands. Proc Natl Acad Sci USA.
93:9821–9826. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li LC and Dahiya R: MethPrimer: designing
primers for methylation PCRs. Bioinformatics. 18:1427–1431. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Rice P, Longden I and Bleasby A: EMBOSS:
The European Molecular Biology Open Software Suite. Trends Genet.
16:276–277. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Davuluri RV, Grosse I and Zhang MQ:
Computational identification of promoters and first exons in the
human genome. Nat Genet. 29:412–417. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Prestridge DS: Predicting Pol II promoter
sequences using transcription factor binding sites. J Mol Biol.
249:923–932. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Clément G, Bosman FT, Fontolliet C and
Benhattar J: Monoallelic methylation of the APC promoter is altered
in normal gastric mucosa associated with neoplastic lesions. Cancer
Res. 64:6867–6873. 2004.PubMed/NCBI
|
|
30
|
Sakamoto Y, Kitazawa R, Maeda S and
Kitazawa S: Methylation of CpG loci in 5′ -flanking region alters
steady-state expression of adenomatous polyposis coli gene in colon
cancer cell lines. J Cell Biol. 80:415–423. 2001.
|
|
31
|
Lind GE, Thorstensen L, Løvig T, Meling
GI, Hamelin R, Rognum TO, Esteller M and Lothe RA: A CpG island
hypermetylation profile of primary colorectal carcinomas and colon
cancer cell lines. Mol Cancer. 3:282004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Adachi Y, Itoh F, Yamamoto H, Arimura Y,
Kikkawa-Okabe Y, Miyazaki K, Carbone DP and Imai K: Expression of
angiomodulin (tumor-derived adhesion factor/mac25) in invading
tumor cells correlates with poor prognosis in human colorectal
cancer. Int J Cancer. 95:216–222. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lin J, Lai M, Huang Q, Ma Y, Cui J and
Ruan W: Methylation patterns of IGFBP7 in colon cancer cell lines
are associated with levels of gene expression. J Pathol. 212:83–90.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Nakajima T, Maekita T, Oda I, Gotoda T,
Yamamoto S, Umemura S, Ichinose M, Sugimura T, Ushijima T and Saito
D: Higher methylation levels in gastric mucosae significantly
correlate with higher risk of gastric cancer. Cancer Epidemiol
Biomarkers Prev. 15:2317–2321. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Shen L, Kondo Y, Rosner GL, Xiao L,
Hernandez NS, Vilaythong J, Houlihan PS, Krouse RS, Prasad AR,
Einspahr JG, Buckmeier J, Alberts DS, Hamilton SR and Issa JPJ:
MGMT promoter methylation and field defect in sporadic colorectal
cancer. J Natl Cancer Inst. 97:1330–1338. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Issa JP, Ahuja N, Toyota M, Bronner MP and
Brentnall TA: Accelerated age-related CpG island methylation in
ulcerative colitis. Cancer Res. 61:3573–3577. 2001.PubMed/NCBI
|
|
37
|
Anh PT and Duc NB: The situation with
cancer control in Vietnam. Jpn J Clin Oncol. 32(Suppl): S92–S97.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sung JJ, Lau JY, Young GP, Sano Y, Chiu
HM, Byeon JS, Yeoh KG, Goh KL, Sollano J, Rerknimitr R, Matsuda T,
Wu KC, Ng S, Leung SY, Makharia G, Chong VH, Ho KY, Brooks D,
Lieberman DA and Chan FK; Asia Pacific Working Group on Colorectal
Cancer: Asia Pacific consensus recommendations for colorectal
cancer screening. Gut. 57:1166–1176. 2008. View Article : Google Scholar : PubMed/NCBI
|
